bioRxivImmunology
Epidemiological survey of serum titers from adults against various Gram-negative bacterial V-antigens
M. Kinoshita, M. Shimizu, K. Akiyama, H. Kato, K. Moriyama, T. Sawa
Abstract
The V-antigen, a virulence-associated protein, was first identified in Yersinia pestis more than half a century ago. Since then, other V-antigen homologs and orthologs have been discovered and are now considered vital molecules for the toxic effects mediated by the type III secretion system in infections caused by various pathogenic Gram-negative bacteria. After purifying recombinant V-antigen proteins including PcrV from Pseudomonas aeruginosa, LcrV from Yersinia, LssV from Photorhabdus luminescens, AcrV from Aeromonas salmonicida, and VcrV from Vibrio parahaemolyticus, we developed an enzyme-linked immunoabsorbent assay to measure titers against each V-antigen in the sera collected from 186 adult volunteers. Different titer-specific correlation levels were determined for the five V-antigens. The anti-LcrV and anti-AcrV titers shared the highest correlation with each other, with a correlation coefficient of 0.84. The next highest correlation coefficient was between anti-AcrV and anti-VcrV titers at 0.79, while the lowest correlation was found between anti-LcrV and anti-VcrV titers, which were still higher than 0.7 Sera from mice immunized with one of the five recombinant V-antigens displayed cross-antigenicity with some of the other four V-antigens, supporting the results from the human sera. Thus, the serum anti-V-antigen titer measurement system could potentially be used for epidemiological investigations on various pathogenic Gram-negative bacteria.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Contribution of the Type 3 Secretion System to immunogenicity of a live Yersinia pseudotuberculosis plague vaccine
Anne Derbise, Chloé Guillas, … Christian E. Demeure·VaccinePeer-reviewed·Feb 19, 2025
- Type VI Secretion Promotes Microbial Antagonism and Contributes to Pathogenesis by AHPND-causing Vibrio parahaemolyticus
Damian Cavanagh, Karina L. Martinez Lopez, … Brett Froelich·bioRxiv·Jun 3, 2024
- Human monoclonal antibodies reveal subdominant gonococcal and meningococcal cross-protective antigens
M. Troisi, M. Fabbrini, … An·bioRxiv·Dec 7, 2023
- Interaction Between Yersinia pestis Ail Outer Membrane Protein and the C-Terminal Domain of Human Vitronectin
L. Vasseur, F. Barbault, A. MONARI·bioRxiv·Jan 7, 2024
- Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses
S. E. Jossi, M. Arcuri, … A. F. Cunningham·bioRxiv·Jan 3, 2023
- Characterization of the pscC (Type III secretion) gene of Pseudomonas aeruginosa (PA01) and assessment of immunogenicity of pscC protein in rats
Md Safiul Alam Bhuiyan, Daisy V John, … Kenneth Francis Rodrigues·bioRxiv·Aug 26, 2016